SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
19439722
Source:
http://linkedlifedata.com/resource/pubmed/id/19439722
Search
Subject
(
55
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0042789
,
umls-concept:C0086466
,
umls-concept:C0087111
,
umls-concept:C1272883
,
umls-concept:C1272936
,
umls-concept:C1533685
,
umls-concept:C2348205
pubmed:issue
23
pubmed:dateCreated
2009-6-9
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19439722-19279320
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19439722-20177129
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0401060
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic
,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers
,
http://linkedlifedata.com/resource/pubmed/chemical/Gadolinium
,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-beta
,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides
,
http://linkedlifedata.com/resource/pubmed/chemical/copolymer 1
,
http://linkedlifedata.com/resource/pubmed/chemical/interferon beta-1b
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1526-632X
pubmed:author
pubmed-author:ArnoldDouglas LDL
,
pubmed-author:FoxRobert JRJ
pubmed:issnType
Electronic
pubmed:day
9
pubmed:volume
72
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1972-3
pubmed:dateRevised
2010-3-5
pubmed:meshHeading
pubmed-meshheading:19439722-Adjuvants, Immunologic
,
pubmed-meshheading:19439722-Biological Markers
,
pubmed-meshheading:19439722-Central Nervous System
,
pubmed-meshheading:19439722-Disease Progression
,
pubmed-meshheading:19439722-Gadolinium
,
pubmed-meshheading:19439722-Humans
,
pubmed-meshheading:19439722-Injections
,
pubmed-meshheading:19439722-Interferon-beta
,
pubmed-meshheading:19439722-Magnetic Resonance Imaging
,
pubmed-meshheading:19439722-Multiple Sclerosis
,
pubmed-meshheading:19439722-Outcome Assessment (Health Care)
,
pubmed-meshheading:19439722-Peptides
,
pubmed-meshheading:19439722-Predictive Value of Tests
,
pubmed-meshheading:19439722-Randomized Controlled Trials as Topic
,
pubmed-meshheading:19439722-Recurrence
,
pubmed-meshheading:19439722-Sensitivity and Specificity
,
pubmed-meshheading:19439722-Treatment Outcome
pubmed:year
2009
pubmed:articleTitle
Seeing injectable MS therapies differently: they are more similar than different.
pubmed:publicationType
Editorial
,
Comment